Tigecycline Treatment Causes a Decrease in Fibrinogen Levels

Life-threatening coagulopathy and hypofibrinogenaemia induced by tigecycline in a patient with advanced liver cirrhosis

(2014) Giacomo Rossitto et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Tigecycline: an antibiotic for the twenty-first century

(2013) M. Dryden   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Safety and tolerability of tigecycline for the treatment of complicated skin and soft-tissue and intra-abdominal infections: an analysis based on five European observational studies

(2013) X. Guirao et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Adverse Event Profile of Tigecycline: Data Mining of the Public Version of the U.S. Food and Drug Administration Adverse Event Reporting System

(2012) Kaori Kadoyama et al.   BIOLOGICAL & PHARMACEUTICAL BULLETIN

The urgent need for new antibacterial agents

(2011) R. Wise et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Tigecycline Pharmacokinetics in Subjects With Various Degrees of Renal Function

(2011) Joan M. Korth-Bradley et al.   JOURNAL OF CLINICAL PHARMACOLOGY

The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii

(2011) Jung-Jr Ye et al.   JOURNAL OF INFECTION

Severe coagulation disorder with hypofibrinogenemia associated with the use of tigecycline

(2010) Herwig Pieringer et al.   ANNALS OF HEMATOLOGY

Multidrug-Resistant Gram-Negative Infections

(2009) Helen Giamarellou et al.   DRUGS

Fibrinogen metabolic responses to trauma

(2009) Wenjun Martini   Scandinavian Journal of Trauma Resuscitation & Emergency Medicine

A Phase 3, open-label, non-comparative study of tigecycline in the treatment of patients with selected serious infections due to resistant Gram-negative organisms including Enterobacter species, Acinetobacter baumannii and Klebsiella pneumoniae

(2008) K. Vasilev et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY